
zzso zzso was the first zzso human insulin analogue to be zzso in the European Union, in the early zzso for the treatment of diabetes zzso It has about a zzso increase in affinity for the zzso growth factor 1 zzso zzso compared with natural human insulin, which may stimulate zzso zzso Four European zzso studies published in 2009 examined the risk of cancer in diabetic patients treated with insulin zzso One of these studies, conducted in Germany, showed a statistically significant zzso increase in the risk of zzso Two other studies, one in Scotland and the other in Sweden, showed an increase in the risk of breast zzso The fourth study, conducted in the zzso showed a lower risk of cancer in patients on zzso This evidence is inconclusive, notably because these studies did not take zzso factors into zzso Nevertheless, the results tend to be similar and consistent with certain pharmacological zzso In practice, pending more solid evidence, these zzso results should be taken into account when weighing the zzso balance of insulin therapy for diabetic patients, on a case by case basis, depending on the type of diabetes, patient history, life zzso and the possible practical advantages of insulin zzso 

